Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 52

1.

Prospective studies of total and ionized serum calcium in relation to incident and fatal ovarian cancer.

Schwartz GG, Skinner HG.

Gynecol Oncol. 2013 Apr;129(1):169-72. doi: 10.1016/j.ygyno.2012.12.046.

PMID:
23313738
2.

A prospective study of total and ionized serum calcium and time to fatal prostate cancer.

Schwartz GG, Skinner HG.

Cancer Epidemiol Biomarkers Prev. 2012 Oct;21(10):1768-73. doi: 10.1158/1055-9965.EPI-12-0585.

3.

Tubal ligation and fatal ovarian cancer in a large prospective cohort study.

Miracle-McMahill HL, Calle EE, Kosinski AS, Rodriguez C, Wingo PA, Thun MJ, Heath CW Jr.

Am J Epidemiol. 1997 Feb 15;145(4):349-57.

4.

Infertility and risk of fatal ovarian cancer in a prospective cohort of US women.

Rodriguez C, Tatham LM, Calle EE, Thun MJ, Jacobs EJ, Heath CW Jr.

Cancer Causes Control. 1998 Dec;9(6):645-51.

PMID:
10189051
5.

Dietary fiber intake and ovarian cancer risk: a prospective cohort study.

Silvera SA, Jain M, Howe GR, Miller AB, Rohan TE.

Cancer Causes Control. 2007 Apr;18(3):335-41.

PMID:
17285261
6.

Serum calcium and risk of gastrointestinal cancer in the Swedish AMORIS study.

Wulaningsih W, Michaelsson K, Garmo H, Hammar N, Jungner I, Walldius G, Lambe M, Holmberg L, Van Hemelrijck M.

BMC Public Health. 2013 Jul 17;13:663. doi: 10.1186/1471-2458-13-663.

8.

Estrogen replacement therapy and fatal ovarian cancer.

Rodriguez C, Calle EE, Coates RJ, Miracle-McMahill HL, Thun MJ, Heath CW Jr.

Am J Epidemiol. 1995 May 1;141(9):828-35.

PMID:
7717359
9.

Intake of coffee and tea and risk of ovarian cancer: a prospective cohort study.

Silvera SA, Jain M, Howe GR, Miller AB, Rohan TE.

Nutr Cancer. 2007;58(1):22-7.

PMID:
17571963
10.

A prospective study of total and ionized serum calcium and fatal prostate cancer.

Skinner HG, Schwartz GG.

Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):575-8. doi: 10.1158/1055-9965.EPI-08-0915.

11.

Circulating soluble Fas levels and risk of ovarian cancer.

Akhmedkhanov A, Lundin E, Guller S, Lukanova A, Micheli A, Ma Y, Afanasyeva Y, Zeleniuch-Jacquotte A, Krogh V, Lenner P, Muti P, Rinaldi S, Kaaks R, Berrino F, Hallmans G, Toniolo P.

BMC Cancer. 2003 Dec 22;3:33.

12.

Glycaemic index, glycaemic load and ovarian cancer risk: a prospective cohort study.

Silvera SA, Jain M, Howe GR, Miller AB, Rohan TE.

Public Health Nutr. 2007 Oct;10(10):1076-81.

PMID:
17381931
13.

Serum calcium and incident and fatal prostate cancer in the National Health and Nutrition Examination Survey.

Skinner HG, Schwartz GG.

Cancer Epidemiol Biomarkers Prev. 2008 Sep;17(9):2302-5. doi: 10.1158/1055-9965.EPI-08-0365.

14.

Increased cardiovascular mortality and normalized serum calcium in patients with mild hypercalcemia followed up for 25 years.

Lundgren E, Lind L, Palmér M, Jakobsson S, Ljunghall S, Rastad J.

Surgery. 2001 Dec;130(6):978-85.

PMID:
11742326
15.
16.

Serum calcium and incident and fatal prostate cancer in the Swedish AMORIS study.

Van Hemelrijck M, Hermans R, Michaelsson K, Melvin J, Garmo H, Hammar N, Jungner I, Walldius G, Holmberg L.

Cancer Causes Control. 2012 Aug;23(8):1349-58. doi: 10.1007/s10552-012-0015-x.

PMID:
22710746
17.

Serum calcium and breast cancer risk: results from a prospective cohort study of 7,847 women.

Almquist M, Manjer J, Bondeson L, Bondeson AG.

Cancer Causes Control. 2007 Aug;18(6):595-602.

PMID:
17410477
18.

Conjoint effects of serum calcium and phosphate on risk of total, cardiovascular, and noncardiovascular mortality in the community.

Larsson TE, Olauson H, Hagström E, Ingelsson E, Arnlöv J, Lind L, Sundström J.

Arterioscler Thromb Vasc Biol. 2010 Feb;30(2):333-9. doi: 10.1161/ATVBAHA.109.196675.

19.

Serum folate and cancer mortality among U.S. adults: findings from the Third National Health and Nutritional Examination Survey linked mortality file.

Yang Q, Bostick RM, Friedman JM, Flanders WD.

Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1439-47. doi: 10.1158/1055-9965.EPI-08-0908.

20.

Casting light on 25-hydroxyvitamin D deficiency in ovarian cancer: a study from the NHANES.

Bakhru A, Mallinger JB, Buckanovich RJ, Griggs JJ.

Gynecol Oncol. 2010 Nov;119(2):314-8. doi: 10.1016/j.ygyno.2010.07.006.

PMID:
20684976
Items per page

Supplemental Content

Support Center